XML 21 R8.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Mar. 28, 2025
Mar. 29, 2024
Mar. 31, 2023
Cash flows from operating activities:      
Net (loss) income $ (72,763) $ 152,888 $ 187,494
Adjustments to reconcile net (loss) income to net cash provided by operating activities:      
Depreciation and amortization 64,502 71,382 50,808
Amortization of deferred financing costs 2,513 527 99
Deferred income taxes (16,301) (18,613) (40,116)
Stock-based compensation 41,868 42,457 61,798
Loss on change in fair value of forward repurchase contract 34,752 0 0
Change in fair value of contingent consideration 0 0 (2,800)
Impairment of long-lived assets 0 13,218 0
Provisions for inventory and expected credit losses 9,216 10,286 (1,438)
Change in fair value of marketable securities 0 3,579 (7,471)
Other non-cash reconciling items 6,984 70 285
Changes in operating assets and liabilities:      
Trade accounts receivable 33,081 (7,964) (12,484)
Accounts receivable - other 155 (1,035) 2,226
Inventories (30,160) (15,848) (75,150)
Prepaid expenses and other assets (4,756) (40,231) (23,263)
Trade accounts payable 4,044 (12,653) 11,958
Due to and from related party 5,115 5,231 18,326
Accrued expenses and other current and long-term liabilities (16,337) (21,579) 22,934
Net cash provided by operating activities 61,913 181,715 193,206
Cash flows from investing activities:      
Purchases of property, plant and equipment (39,955) (124,772) (79,775)
Purchases of intangible assets (1,180) 0 0
Acquisition of business, net of cash acquired and working capital adjustment 319 (408,119) (19,921)
Sales in marketable securities 0 16,175 0
Net cash used in investing activities (40,816) (516,716) (99,696)
Cash flows from financing activities:      
Loans made to related party 0 0 (7,500)
Borrowings of 2023 Term Loan Facility, net of deferred financing costs 0 245,452 0
Net proceeds from Refinanced 2023 Term Loan Facility 193,081 0 0
Repayments of other debt 0 (842) 0
Finance lease payments (1,201) (142) 0
Receipts on related party notes receivable 1,875 3,750 2,812
Payments for taxes related to net share settlement of equity awards (16,238) (25,900) (18,061)
Proceeds from issuance of common stock under employee purchase plan 3,511 3,635 2,793
Repurchases of common stock (853,921) 0 0
Net proceeds from issuance of common stock 665,850 0 0
Dividends paid to non-controlling interest (19) 0 (42)
Payments of debt issuance costs 0 (1,450) 0
Net cash (used in) provided by financing activities (112,062) 198,878 (19,998)
Effect of exchange rate changes on cash and cash equivalents and restricted cash (89) (421) (4,606)
Net (decrease) increase in cash and cash equivalents and restricted cash (91,054) (136,544) 68,906
Cash and cash equivalents and restricted cash at beginning of period 222,161 358,705 289,799
Cash and cash equivalents and restricted cash at end of period: 131,107 222,161 358,705
Reconciliation of cash and cash equivalents and restricted cash:      
Cash and cash equivalents at beginning of period 212,143 351,576 282,383
Restricted cash at beginning of period 10,018 7,129 7,416
Cash and cash equivalents at end of period 121,334 212,143 351,576
Restricted cash at end of period 9,773 10,018 7,129
Supplemental disclosures of cash flow information:      
Cash paid for interest 21,959 10,153 1,923
Cash paid for income taxes, net of refunds 11,639 89,927 58,209
Non-cash transactions:      
Property, plant and equipment purchases included in trade accounts payable and accrued expenses (4,463) (4,157) (16,369)
Right-of-use assets obtained in exchange for lease liabilities 6,999 10,450 4,870
Assets held for sale transferred from property, plant and equipment, net 16,508 0 0
2020 Term Loan Facility      
Cash flows from financing activities:      
Repayment of Term Loan Facility 0 (25,000) 0
2023 Term Loan Facility      
Cash flows from financing activities:      
Repayment of Term Loan Facility $ (105,000) $ (625) $ 0